Strontium- and zinc-alginate hydrogels for bone tissue engineering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Biotechnology

Background:

• Bone autografts have limitations for treating bone defects.
• Developing advanced bone replacement materials is crucial for healthcare.
• Alginate hydrogels offer a versatile platform for tissue engineering.

Purpose of the Study:

• To engineer RGD-modified alginate hydrogels crosslinked with strontium and zinc ions for bone regeneration.
• To evaluate the impact of strontium and zinc ions on hydrogel properties and cell behavior.
• To assess the potential of these hydrogels as bone void fillers.

Main Methods:

• Modification of alginate hydrogels with arginine-glycine-aspartic acid (RGD).
• Crosslinking hydrogels with strontium, zinc, and calcium ions.
• Assessment of hydrogel stiffness, stability, and ion release kinetics.
• Culture of Saos-2 osteoblast-like cells within hydrogels and evaluation of proliferation, gene expression (RUNX2, COL1A1, BSP), and alkaline phosphatase (ALP) activity.

Main Results:

• Strontium- and calcium-crosslinked gels exhibited comparable stiffness but varied degradation rates.
• High mannuronic acid (high M) alginate gels degraded faster and supported Saos-2 cell proliferation.
• Sustained strontium release from high M gels was biologically relevant, promoting osteoblast differentiation markers and ALP activity.

Conclusions:

• RGD-modified alginate hydrogels crosslinked with strontium and zinc ions show significant potential for bone tissue engineering.
• The tunable degradation and ion release properties of these hydrogels support osteoblast function.
• This approach can be integrated with other alginate-based systems or adapted for diverse tissue engineering applications.